C

Cuu Long Pharmaceutical JSC
VN:DCL

Watchlist Manager
Cuu Long Pharmaceutical JSC
VN:DCL
Watchlist
Price: 26 800 VND 0.19% Market Closed
Market Cap: 2T VND
Have any thoughts about
Cuu Long Pharmaceutical JSC?
Write Note

Intrinsic Value

The intrinsic value of one DCL stock under the Base Case scenario is 24 894.23 VND. Compared to the current market price of 26 800 VND, Cuu Long Pharmaceutical JSC is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DCL Intrinsic Value
24 894.23 VND
Overvaluation 7%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Cuu Long Pharmaceutical JSC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DCL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DCL?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Cuu Long Pharmaceutical JSC

Provide an overview of the primary business activities
of Cuu Long Pharmaceutical JSC.

What unique competitive advantages
does Cuu Long Pharmaceutical JSC hold over its rivals?

What risks and challenges
does Cuu Long Pharmaceutical JSC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cuu Long Pharmaceutical JSC.

Provide P/S
for Cuu Long Pharmaceutical JSC.

Provide P/E
for Cuu Long Pharmaceutical JSC.

Provide P/OCF
for Cuu Long Pharmaceutical JSC.

Provide P/FCFE
for Cuu Long Pharmaceutical JSC.

Provide P/B
for Cuu Long Pharmaceutical JSC.

Provide EV/S
for Cuu Long Pharmaceutical JSC.

Provide EV/GP
for Cuu Long Pharmaceutical JSC.

Provide EV/EBITDA
for Cuu Long Pharmaceutical JSC.

Provide EV/EBIT
for Cuu Long Pharmaceutical JSC.

Provide EV/OCF
for Cuu Long Pharmaceutical JSC.

Provide EV/FCFF
for Cuu Long Pharmaceutical JSC.

Provide EV/IC
for Cuu Long Pharmaceutical JSC.

Compare the intrinsic valuations
of Cuu Long Pharmaceutical JSC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cuu Long Pharmaceutical JSC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cuu Long Pharmaceutical JSC compared to its peers.

Compare the P/E ratios
of Cuu Long Pharmaceutical JSC against its peers.

Discuss the investment returns and shareholder value creation
comparing Cuu Long Pharmaceutical JSC with its peers.

Analyze the financial leverage
of Cuu Long Pharmaceutical JSC compared to its main competitors.

Show all profitability ratios
for Cuu Long Pharmaceutical JSC.

Provide ROE
for Cuu Long Pharmaceutical JSC.

Provide ROA
for Cuu Long Pharmaceutical JSC.

Provide ROIC
for Cuu Long Pharmaceutical JSC.

Provide ROCE
for Cuu Long Pharmaceutical JSC.

Provide Gross Margin
for Cuu Long Pharmaceutical JSC.

Provide Operating Margin
for Cuu Long Pharmaceutical JSC.

Provide Net Margin
for Cuu Long Pharmaceutical JSC.

Provide FCF Margin
for Cuu Long Pharmaceutical JSC.

Show all solvency ratios
for Cuu Long Pharmaceutical JSC.

Provide D/E Ratio
for Cuu Long Pharmaceutical JSC.

Provide D/A Ratio
for Cuu Long Pharmaceutical JSC.

Provide Interest Coverage Ratio
for Cuu Long Pharmaceutical JSC.

Provide Altman Z-Score Ratio
for Cuu Long Pharmaceutical JSC.

Provide Quick Ratio
for Cuu Long Pharmaceutical JSC.

Provide Current Ratio
for Cuu Long Pharmaceutical JSC.

Provide Cash Ratio
for Cuu Long Pharmaceutical JSC.

What is the historical Revenue growth
over the last 5 years for Cuu Long Pharmaceutical JSC?

What is the historical Net Income growth
over the last 5 years for Cuu Long Pharmaceutical JSC?

What is the current Free Cash Flow
of Cuu Long Pharmaceutical JSC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cuu Long Pharmaceutical JSC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cuu Long Pharmaceutical JSC

Current Assets 1.5T
Cash & Short-Term Investments 221.9B
Receivables 788.6B
Other Current Assets 503.3B
Non-Current Assets 900.1B
PP&E 860.4B
Intangibles 23.2B
Other Non-Current Assets 16.5B
Current Liabilities 679.2B
Accounts Payable 124B
Accrued Liabilities 32.7B
Short-Term Debt 373.1B
Other Current Liabilities 149.4B
Non-Current Liabilities 273B
Long-Term Debt 254.5B
Other Non-Current Liabilities 18.6B
Efficiency

Earnings Waterfall
Cuu Long Pharmaceutical JSC

Revenue
1.2T VND
Cost of Revenue
-962.9B VND
Gross Profit
222.3B VND
Operating Expenses
-127.9B VND
Operating Income
94.3B VND
Other Expenses
-25.1B VND
Net Income
69.3B VND

Free Cash Flow Analysis
Cuu Long Pharmaceutical JSC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DCL Profitability Score
Profitability Due Diligence

Cuu Long Pharmaceutical JSC's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Positive Operating Income
Positive Net Income
44/100
Profitability
Score

Cuu Long Pharmaceutical JSC's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

DCL Solvency Score
Solvency Due Diligence

Cuu Long Pharmaceutical JSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
50/100
Solvency
Score

Cuu Long Pharmaceutical JSC's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DCL Price Targets Summary
Cuu Long Pharmaceutical JSC

There are no price targets for DCL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DCL?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DCL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Cuu Long Pharmaceutical JSC

Country

Vietnam

Industry

Pharmaceuticals

Market Cap

2T VND

Dividend Yield

0%

Description

Cuu Long Pharmaceutical JSC engages in the manufacture, sale, import, and export of pharmaceutical, capsules, and medical instruments. The company is headquartered in Vinh Long, Vinh Long and currently employs 934 full-time employees. The company went IPO on 2008-09-17. The firm manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. The company is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.

Contact

VINH LONG
Vinh Long
So 150 duong 14/9, phuong 5
+842703822533
dcl.com.vn

IPO

2008-09-17

Employees

934

Officers

Deputy CEO in charge of Production & SC and Member of Management Board
Mr. Duc Trong Nguyen
CEO, Management Board Member, VP of Pharmaceutical Sales & Marketing Director
Mr. The Ba Nguyen
Deputy General Director & Member of Management Board
Mr. Truong Xuan Nghiem
Member of Management Board & General Director
Mr. Ban Van Nguyen
Chief Accountant
Mr. Thuong Lam Minh Nguyen

See Also

Discover More
What is the Intrinsic Value of one DCL stock?

The intrinsic value of one DCL stock under the Base Case scenario is 24 894.23 VND.

Is DCL stock undervalued or overvalued?

Compared to the current market price of 26 800 VND, Cuu Long Pharmaceutical JSC is Overvalued by 7%.

Back to Top